Drug profile · INN
amenamevir
AMENALIEF
amenamevir (AMENALIEF) is a helicase primate complex inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — amenamevir
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
amenamevir (AMENALIEF) is a helicase primate complex inhibitor.
Key facts
INN amenamevir
Brand AMENALIEF
Mechanism Helicase primate complex inhibitor
Target Helicase primase complex
Mechanism of action
Helicase primate complex inhibitor
Primary target: Helicase primase complex
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is amenamevir?
amenamevir (AMENALIEF) is a helicase primate complex inhibitor.
What is the brand name for amenamevir?
AMENALIEF is a marketed brand name for amenamevir. Check FDA Drugs@FDA for the current US label holder and prescribing information.